Newsletter Subject

Investors Reap 400% Profit from FDA-Approved Drug!

From

usafinanceinsider.com

Email Address

news@ufi.usafinanceinsider.com

Sent On

Fri, Aug 30, 2024 05:45 PM

Email Preheader Text

The FDA has approved a drug that could revolutionize the world's cancer treatment, a share of which

The FDA has approved a drug that could revolutionize the world's cancer treatment, a share of which is worth $4! Click Here [UFI](usafinanceinsider.com) [UFI](usafinanceinsider.com) The FDA has approved a drug that could revolutionize the world's cancer treatment, a share of which is worth $4! [Click Here]( When the FDA approves new drugs, investors' timely actions have brought them [400% profits in a day.]( And you won't miss your chance to buy a fast-growing stock that could bring you big profits! To keep up to date we recommend [click here]( for further readings. All the best, Simmy Adelman, Publisher Behind the Markets You are receiving this email from USAFinanceInsider.com, a valued member of the Stark Media LLC family. We appreciate your subscription and are dedicated to providing you with valuable content.
If you no longer wish to receive these communications, you can easily unsubscribe by [clicking here](. The process is quick and straightforward. Your feedback is important to Stark Media LLC. Our dedicated support team at support@USAFinanceInsider.com is always ready to help you if you have any questions. Copyright © 2024 Stark Media LLC. All Rights Reserved. Unauthorized reproduction, copying, or distribution of our content, in whole or in part, is strictly prohibited without written permission from Stark Media LLC. We appreciate your respect for our intellectual property. Contact Us: support@USAFinanceInsider.com You can find our [Privacy Policy]( and [Terms & Conditions]( by following these links. 222 Delaware St, Ste 2071 New Castle, DE 19720

Marketing emails from usafinanceinsider.com

View More
Sent On

04/09/2024

Sent On

03/09/2024

Sent On

01/09/2024

Sent On

31/08/2024

Sent On

29/08/2024

Sent On

28/08/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.